- Companies
- PhaBuilder
PhaBuilder Valuation, Funding & Investors
PhaBuilder is valued at $287M as of February 2023.
Last PhaBuilder valuation
$287M
Series A · Feb 2023
Last PhaBuilder funding round
$52M
Series A · Feb 2023
Cumulative funding PhaBuilder raised
$112M
across 4 funding rounds
Key investors in PhaBuilder
HSG
GRC SinoGreen Fund
Z&H Investment
Sino Biological
Shenzhen Guozhong Venture Capital Management
FTZ Fund
About PhaBuilder
PhaBuilder is a synthetic biology firm engineering halophilic microbes for industrial applications through next-generation biotechnology. It produces biodegradable PHA polymers, ectoine as a pharmaceutical intermediate, and cadaverine for Nylon 56 precursors. Based in Beijing at the China-Germany Industrial Park, PhaBuilder develops products in its synthetic biology facility and constructs a PHA production plant in Yichang, Hubei Province. The company expands with additional large-scale bases across China.
Founded
2021
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Valuation
$287M (Feb 2023)
PhaBuilder Valuation
PhaBuilder is currently valued at $287M, based on its Series A in February 2023. Read the announcement ↗
The $52M round was led by China National Petroleum Group Kunlun Capital, with participation from FTZ Fund, Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership), Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership), Enterprise Mixed Ownership Reform Fund, Lhasa Alec Investment Consulting and 6 other investors.
PhaBuilder valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Feb 2023 | Series A | $287M |
PhaBuilder Funding History
PhaBuilder has raised a total of $112M across 4 funding rounds.
PhaBuilder's first fundraising round was a $8M angel round in July 2021. The most recent completed round was a $52M Series A in February 2023.
PhaBuilder funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Feb 2023 | Series A | China National Petroleum Group Kunlun Capital (lead); FTZ Fund; Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership); Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership); Enterprise Mixed Ownership Reform Fund; Lhasa Alec Investment Consulting; Mingqu Capital; Sino Biological; GRC SinoGreen Fund; Agricultural Fund of China; Z&H Investment; HSG | $52M | $287M | - |
| Nov 2022 | Series A | Sino Biological (lead) | $13M | - | - |
| Jan 2022 | Series A | Chengtong Mixed Reform (lead); Huakong Electronic Technology; Shenzhen Guozhong Venture Capital Management; Beijing Linkong Xingrong Investment; GRC SinoGreen Fund; Z&H Investment; HSG | $39M | - | - |
| Jul 2021 | Angel | HSG (lead); SEE Fund; Ningbo Qiwu Management Consulting Partnership | $8M | - | Beijing PhaBuilder Biotechnology Co., Ltd. develops synthetic biology technologies to produce PHA (Polyhydroxyalkanoates), a family of biodegradable polymers including PHB, PHBV, and P34HB, for applications in medical, fashion, 3D printing, packaging, and consumer goods. The company engineers halophilic microorganisms using non-grain carbon sources like straw and kitchen waste, integrating Industry 4.0 principles for high-efficiency, low-carbon biomanufacturing. PhaBuilder promotes a 'PHA Life' concept to create green, low-carbon lifestyles by replacing traditional plastics with biodegradable PHA products. Founded in 2021, it originated from Tsinghua University technology by Professor George Guo-Qiang Chen. |
Who has invested in PhaBuilder?
18 investors have backed PhaBuilder across its funding rounds, including HSG, GRC SinoGreen Fund, Z&H Investment, Sino Biological, Shenzhen Guozhong Venture Capital Management and FTZ Fund.
Lead investors include China National Petroleum Group Kunlun Capital, Sino Biological, Chengtong Mixed Reform and HSG.
PhaBuilder Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Jul 2021 | ||
| 2 | Lead | Nov 2022 | ||
| 2 | Participant | Jan 2022 | ||
| 2 | Participant | Jan 2022 | ||
| 1 | Participant | Jan 2022 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Lead | Jan 2022 | ||
| 1 | Participant | Jul 2021 | ||
| 1 | Participant | Jan 2022 | ||
| 1 | Participant | Jul 2021 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Participant | Feb 2023 | ||
This data is available for Pro users. Sign up to see all 18 PhaBuilder investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialPhaBuilder Competitors
PhaBuilder competitors include listed companies like Itafos and Steady Energy, and private ones like BioElements, Hydrosat, Absolute and CAPSERO.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $6M | - | $200M | 33.3x | ||
| Private | - | - | $180M | - | ||
| Private | - | - | $500M | - | ||
| Private | - | - | $113M | - | ||
| Publicly listed | $558M | $189M | $288M | 0.5x | ||
| Publicly listed | $302K | ($10M) | $337M | - |
PhaBuilder Public Comps
PhaBuilder is still privately-owned, but its public comps include Itafos, Balmer Lawrie & Co, CW Enerji, Polyplex Corp, Ranpak, Nilkamal, Jindal Poly Films, Tredegar, Envipco Holding and Nampak.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $558M | $189M | 0.6x | 0.5x | 1.7x | 3.3x | |||
| $266M | $38M | 1.0x | - | 6.9x | - | |||
| $328M | $72M | 1.5x | - | 6.7x | - | |||
| $744M | $41M | 0.8x | - | 13.9x | - | |||
| $395M | $54M | 1.7x | 1.6x | 12.2x | 7.8x | |||
| $394M | $34M | 0.9x | 0.8x | 10.0x | 9.5x | |||
| $293M | ($119M) | 1.5x | - | (3.7x) | - | |||
| $723M | $56M | 0.4x | - | 5.4x | - | |||
This data is available for Pro users. Sign up to see all PhaBuilder competitors and their valuation data. Start Free Trial | ||||||||
Common questions about PhaBuilder
| When was PhaBuilder founded? | PhaBuilder was founded in 2021. |
| Where is PhaBuilder headquartered? | PhaBuilder is headquartered in Beijing, China. |
| Is PhaBuilder publicly listed? | No, PhaBuilder is a private, VC-backed company. |
| What is PhaBuilder's valuation? | PhaBuilder was last valued at $287M in its Series A in February 2023. |
| How much funding has PhaBuilder raised? | PhaBuilder has raised $112M across 4 funding rounds. |
| What was PhaBuilder's last funding round? | PhaBuilder's last funding round was a $52M Series A in February 2023, led by China National Petroleum Group Kunlun Capital. |
| Who are PhaBuilder's investors? | PhaBuilder's investors include HSG, Sino Biological, GRC SinoGreen Fund, Z&H Investment, Huakong Electronic Technology, FTZ Fund, Chengtong Mixed Reform, SEE Fund, Shenzhen Guozhong Venture Capital Management, Ningbo Qiwu Management Consulting Partnership and 8 others. |
| Which companies are comparable to PhaBuilder? | Companies comparable to PhaBuilder include BioElements, Hydrosat, Absolute, CAPSERO, Itafos and Steady Energy. |
See companies similar to PhaBuilder
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




